Exercise and Sleep in Parkinson's Disease
The Effect of Different Exercise Modalities on Sleep Quality and Architecture in People With Parkinson's Disease
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will investigate the impact of two common exercise modalities, cardiovascular and resistance training, on sleep quality and architecture in persons with Parkinson's disease (PD), and whether these potential positive changes in sleep are associated with improvements in brain plasticity and different quality of life (QoL)-related aspects. Participants will perform either cardiovascular training (CT) or resistance training (RT) for 12 weeks, at least two times/week. The assessments will be performed at baseline and after training by an assessor blinded to the participants' group allocation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Sep 2021
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2020
CompletedFirst Posted
Study publicly available on registry
September 22, 2020
CompletedStudy Start
First participant enrolled
September 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMarch 15, 2024
March 1, 2024
3.2 years
September 9, 2020
March 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Sleep efficiency (SE)
Actigraphy; SE = total sleep time/time spent in bed.
12 weeks
Subjective sleep quality
Parkinson's Disease Sleep Scale version 2 (PDSS-2); Score range from 0-60; higher scores represent worse sleep quality.
12 weeks
Objective sleep measurements, including duration and percentage of sleep stages, total sleep time (TLT), wake after sleep onset (WASO), sleep latency (SL).
Polysomnography combined with electroencephalogram
12 weeks
Secondary Outcomes (6)
Motor function
12 weeks
Cognition
12 weeks
Fatigue
12 weeks
Psychosocial functioning
12 weeks
Quality of life-related aspects in Parkinson's disease
12 weeks
- +1 more secondary outcomes
Other Outcomes (4)
Intra-cortical facilitation
12 weeks
Short intra-cortical inhibition
12 weeks
Silent period
12 weeks
- +1 more other outcomes
Study Arms (2)
Cardiovascular training
EXPERIMENTALCardiovascular training (CT) will be performed on a recumbent stepper. CT will start at low intensity, and through a linear progression will reach vigorous intensity; then, this intensity will be maintained until the end of the intervention. Each session will include five minutes of warm-up and cool-down performed at the beginning and the end of the training, respectively. Furthermore, five minutes of stretching will be performed after the cool down. CT's sessions will approximately last 45 minutes and will be interspersed with at least 48 hours of recovery.
Resistance training
EXPERIMENTALResistance training (RT) intensity will be estimated using the percentage of one-maximal repetition (1-RM) defined as the maximal weight liftable for ten maximal repetitions with proper form. The program will include five exercises (leg press, lat machine, leg extension, leg curl, bench press) and will start at high-volume low-intensity. RT will follow a periodization to reach high-intensity low-volume at the end of the intervention (week 12). The training sessions will start with five-minute of warm-up performed on a recumbent stepper and will end with five-minute of stretching (cool-down). RT's sessions will approximately last 45 minutes and will be interspersed with at least 48 hours of recovery.
Interventions
Eligibility Criteria
You may qualify if:
- Persons with mild-moderate idiopathic Parkinson's Disease (Modified Hoehn \& Yahr Scale stages 1-3);
- On a stable dosage of medication during the previous month;
- Having poor sleep quality defined as a score \> 18 in the PDSS-2(scores above this cut-off value define clinically relevant sleep disorders);
You may not qualify if:
- Having atypical parkinsonism, dementia or any other neurological, psychiatric or cardiovascular comorbidity affecting the ability to perform exercise;
- Presenting severe untreated obstructive sleep apnea (OSA);
- Having a Montreal Cognitive Assessment (MoCA) score \<21
- Having a Beck Depression Inventory (BDI version 2) score \>4
- Having absolute contraindications to exercise and to undergo transcranial magnetic stimulation (TMS);
- Currently are or will be enrolled in a drug or exercise trial during the duration of the study;
- Having participated in a structured exercise program \> 2 times per week in the two months prior to the enrollment in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- Jewish Rehabilitation Hospitalcollaborator
Study Sites (1)
Jewish Rehabiliation Hospital
Laval, Quebec, H7V 1R2, Canada
Related Publications (2)
Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
PMID: 38588457DERIVEDErnst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
PMID: 36602886DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 9, 2020
First Posted
September 22, 2020
Study Start
September 15, 2021
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
March 15, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
Results will be published in peer-review journals.